Global Checkpoint Inhibitors for Treating Cancer Sales Market Report 2018

June 2018 | 101 pages | ID: GFEF0FC52B0EN
QYResearch

Abstracts

This report studies the global Checkpoint Inhibitors for Treating Cancer market status and forecast, categorizes the global Checkpoint Inhibitors for Treating Cancer market size (value & volume) by key players, type, application, and region.
This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
Those four kinds of checkpoint inhibitors are mainly used to treat melanoma, bladder cancer and others. In 2015, melanoma treatment consumed checkpoint inhibitors took a share of 80.53%. In 2016, melanoma treatment consumed checkpoint inhibitors will be 68153g. Bladder cancer treatment consumed checkpoint inhibitors will be 1978g.
Although YERVOY® (ipilimumab), OPDIVO® (nivolumab), KEYTRUDA® (pembrolizumab) and Tecentriq® (atezolizumab) are four indispensable medicines for cancer treatment, they also has many shortages. Firstly, they all have side effect for patient. Secondly, price of checkpoint inhibitors for treating cancer is too expensive. CTLA-4 inhibitors price is about 118.2 USD/mg in 2016. PD-1 inhibitors price is about 28.6 USD/mg in 2016. PD-L1 inhibitors price is about 30.5 USD/mg in 2016. For most patients, the price is unbearable.

The global Checkpoint Inhibitors for Treating Cancer market is valued at 4690 million US$ in 2017 and will reach 29000 million US$ by the end of 2025, growing at a CAGR of 25.6% during 2018-2025.
The major players covered in this report

• Bristol-Myers Squibb(BMS)
• Merck
• Roche

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• United States
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• PD-1 Inhibitors
• PD-L1 Inhibitors
• CTLA-4 Inhibitors

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Melanoma Treatment
• Bladder Cancer Treatment
• Other

The study objectives of this report are:

• To analyze and study the global Checkpoint Inhibitors for Treating Cancer sales, value, status (2013-2017) and forecast (2018-2025);
• To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
• Focuses on the key Checkpoint Inhibitors for Treating Cancer players, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Checkpoint Inhibitors for Treating Cancer are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Checkpoint Inhibitors for Treating Cancer Manufacturers
Checkpoint Inhibitors for Treating Cancer Distributors/Traders/Wholesalers
Checkpoint Inhibitors for Treating Cancer Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Checkpoint Inhibitors for Treating Cancer market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Checkpoint Inhibitors for Treating Cancer Sales Market Report 2018

1 CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET OVERVIEW

1.1 Product Overview and Scope of Checkpoint Inhibitors for Treating Cancer
1.2 Classification of Checkpoint Inhibitors for Treating Cancer by Product Category
  1.2.1 Global Checkpoint Inhibitors for Treating Cancer Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Checkpoint Inhibitors for Treating Cancer Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 PD-1 Inhibitors
  1.2.4 PD-L1 Inhibitors
  1.2.5 CTLA-4 Inhibitors
1.3 Global Checkpoint Inhibitors for Treating Cancer Market by Application/End Users
  1.3.1 Global Checkpoint Inhibitors for Treating Cancer Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.1 Melanoma Treatment
  1.3.2 Bladder Cancer Treatment
  1.3.3 Other
1.4 Global Checkpoint Inhibitors for Treating Cancer Market by Region
  1.4.1 Global Checkpoint Inhibitors for Treating Cancer Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Checkpoint Inhibitors for Treating Cancer Status and Prospect (2013-2025)
  1.4.3 Europe Checkpoint Inhibitors for Treating Cancer Status and Prospect (2013-2025)
  1.4.4 China Checkpoint Inhibitors for Treating Cancer Status and Prospect (2013-2025)
  1.4.5 Japan Checkpoint Inhibitors for Treating Cancer Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Checkpoint Inhibitors for Treating Cancer Status and Prospect (2013-2025)
  1.4.7 India Checkpoint Inhibitors for Treating Cancer Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Checkpoint Inhibitors for Treating Cancer (2013-2025)
  1.5.1 Global Checkpoint Inhibitors for Treating Cancer Sales and Growth Rate (2013-2025)
  1.5.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Growth Rate (2013-2025)

2 GLOBAL CHECKPOINT INHIBITORS FOR TREATING CANCER COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Checkpoint Inhibitors for Treating Cancer Market Competition by Players/Suppliers
  2.1.1 Global Checkpoint Inhibitors for Treating Cancer Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Checkpoint Inhibitors for Treating Cancer (Volume and Value) by Type
  2.2.1 Global Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Type (2013-2018)
  2.2.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Market Share by Type (2013-2018)
2.3 Global Checkpoint Inhibitors for Treating Cancer (Volume and Value) by Region
  2.3.1 Global Checkpoint Inhibitors for Treating Cancer Sales and Market Share by Region (2013-2018)
  2.3.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Market Share by Region (2013-2018)
2.4 Global Checkpoint Inhibitors for Treating Cancer (Volume) by Application

3 UNITED STATES CHECKPOINT INHIBITORS FOR TREATING CANCER (VOLUME, VALUE AND SALES PRICE)

3.1 United States Checkpoint Inhibitors for Treating Cancer Sales and Value (2013-2018)
  3.1.1 United States Checkpoint Inhibitors for Treating Cancer Sales and Growth Rate (2013-2018)
  3.1.2 United States Checkpoint Inhibitors for Treating Cancer Revenue and Growth Rate (2013-2018)
  3.1.3 United States Checkpoint Inhibitors for Treating Cancer Sales Price Trend (2013-2018)
3.2 United States Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Players (2013-2018)
3.3 United States Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Type (2013-2018)
3.4 United States Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Application (2013-2018)

4 EUROPE CHECKPOINT INHIBITORS FOR TREATING CANCER (VOLUME, VALUE AND SALES PRICE)

4.1 Europe Checkpoint Inhibitors for Treating Cancer Sales and Value (2013-2018)
  4.1.1 Europe Checkpoint Inhibitors for Treating Cancer Sales and Growth Rate (2013-2018)
  4.1.2 Europe Checkpoint Inhibitors for Treating Cancer Revenue and Growth Rate (2013-2018)
  4.1.3 Europe Checkpoint Inhibitors for Treating Cancer Sales Price Trend (2013-2018)
4.2 Europe Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Application (2013-2018)

5 CHINA CHECKPOINT INHIBITORS FOR TREATING CANCER (VOLUME, VALUE AND SALES PRICE)

5.1 China Checkpoint Inhibitors for Treating Cancer Sales and Value (2013-2018)
  5.1.1 China Checkpoint Inhibitors for Treating Cancer Sales and Growth Rate (2013-2018)
  5.1.2 China Checkpoint Inhibitors for Treating Cancer Revenue and Growth Rate (2013-2018)
  5.1.3 China Checkpoint Inhibitors for Treating Cancer Sales Price Trend (2013-2018)
5.2 China Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Players (2013-2018)
5.3 China Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Type (2013-2018)
5.4 China Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Application (2013-2018)

6 JAPAN CHECKPOINT INHIBITORS FOR TREATING CANCER (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Checkpoint Inhibitors for Treating Cancer Sales and Value (2013-2018)
  6.1.1 Japan Checkpoint Inhibitors for Treating Cancer Sales and Growth Rate (2013-2018)
  6.1.2 Japan Checkpoint Inhibitors for Treating Cancer Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Checkpoint Inhibitors for Treating Cancer Sales Price Trend (2013-2018)
6.2 Japan Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA CHECKPOINT INHIBITORS FOR TREATING CANCER (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales and Value (2013-2018)
  7.1.1 Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Checkpoint Inhibitors for Treating Cancer Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Price Trend (2013-2018)
7.2 Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Application (2013-2018)

8 INDIA CHECKPOINT INHIBITORS FOR TREATING CANCER (VOLUME, VALUE AND SALES PRICE)

8.1 India Checkpoint Inhibitors for Treating Cancer Sales and Value (2013-2018)
  8.1.1 India Checkpoint Inhibitors for Treating Cancer Sales and Growth Rate (2013-2018)
  8.1.2 India Checkpoint Inhibitors for Treating Cancer Revenue and Growth Rate (2013-2018)
  8.1.3 India Checkpoint Inhibitors for Treating Cancer Sales Price Trend (2013-2018)
8.2 India Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Players (2013-2018)
8.3 India Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Type (2013-2018)
8.4 India Checkpoint Inhibitors for Treating Cancer Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL CHECKPOINT INHIBITORS FOR TREATING CANCER PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Bristol-Myers Squibb(BMS)
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Checkpoint Inhibitors for Treating Cancer Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Merck
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Checkpoint Inhibitors for Treating Cancer Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Merck Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 Roche
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Checkpoint Inhibitors for Treating Cancer Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Roche Checkpoint Inhibitors for Treating Cancer Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview

10 CHECKPOINT INHIBITORS FOR TREATING CANCER MAUFACTURING COST ANALYSIS

10.1 Checkpoint Inhibitors for Treating Cancer Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Checkpoint Inhibitors for Treating Cancer
10.3 Manufacturing Process Analysis of Checkpoint Inhibitors for Treating Cancer

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Checkpoint Inhibitors for Treating Cancer Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Checkpoint Inhibitors for Treating Cancer Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL CHECKPOINT INHIBITORS FOR TREATING CANCER MARKET FORECAST (2018-2025)

14.1 Global Checkpoint Inhibitors for Treating Cancer Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Checkpoint Inhibitors for Treating Cancer Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Checkpoint Inhibitors for Treating Cancer Price and Trend Forecast (2018-2025)
14.2 Global Checkpoint Inhibitors for Treating Cancer Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Checkpoint Inhibitors for Treating Cancer Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Checkpoint Inhibitors for Treating Cancer Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Checkpoint Inhibitors for Treating Cancer Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 Europe Checkpoint Inhibitors for Treating Cancer Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 China Checkpoint Inhibitors for Treating Cancer Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Checkpoint Inhibitors for Treating Cancer Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Checkpoint Inhibitors for Treating Cancer Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Checkpoint Inhibitors for Treating Cancer Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Checkpoint Inhibitors for Treating Cancer Sales Forecast by Type (2018-2025)
  14.3.2 Global Checkpoint Inhibitors for Treating Cancer Revenue Forecast by Type (2018-2025)
  14.3.3 Global Checkpoint Inhibitors for Treating Cancer Price Forecast by Type (2018-2025)
14.4 Global Checkpoint Inhibitors for Treating Cancer Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Checkpoint Inhibitors for Treating Cancer
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Volume Comparison (g) by Type (2013-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Type (Product Category) in 2017
Figure PD-1 Inhibitors Product Picture
Figure PD-L1 Inhibitors Product Picture
Figure CTLA-4 Inhibitors Product Picture
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Comparison (g) by Application (2013-2025)
Figure Global Sales Market Share of Checkpoint Inhibitors for Treating Cancer by Application in 2017
Figure Melanoma Treatment Examples
Table Key Downstream Customer in Melanoma Treatment
Figure Bladder Cancer Treatment Examples
Table Key Downstream Customer in Bladder Cancer Treatment
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Checkpoint Inhibitors for Treating Cancer Market Size (Million USD) by Regions (2013-2025)
Figure United States Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Volume (g) and Growth Rate (2013-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Checkpoint Inhibitors for Treating Cancer Sales Volume (g) (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Sales (g) of Key Players/Suppliers (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Checkpoint Inhibitors for Treating Cancer Sales Share by Players/Suppliers
Figure 2017 Checkpoint Inhibitors for Treating Cancer Sales Share by Players/Suppliers
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Players
Table 2017 Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Players
Table Global Checkpoint Inhibitors for Treating Cancer Sales (g) and Market Share by Type (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Sales Share (g) by Type (2013-2018)
Figure Sales Market Share of Checkpoint Inhibitors for Treating Cancer by Type (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Growth Rate by Type (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Checkpoint Inhibitors for Treating Cancer by Type (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate by Type (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume (g) and Market Share by Region (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Sales Share by Region (2013-2018)
Figure Sales Market Share of Checkpoint Inhibitors for Treating Cancer by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Growth Rate by Region in 2017
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Checkpoint Inhibitors for Treating Cancer by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Growth Rate by Region in 2017
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Checkpoint Inhibitors for Treating Cancer by Region (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share by Region in 2017
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume (g) and Market Share by Application (2013-2018)
Table Global Checkpoint Inhibitors for Treating Cancer Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Checkpoint Inhibitors for Treating Cancer by Application (2013-2018)
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Market Share by Application (2013-2018)
Figure United States Checkpoint Inhibitors for Treating Cancer Sales (g) and Growth Rate (2013-2018)
Figure United States Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Checkpoint Inhibitors for Treating Cancer Sales Price (USD/mg) Trend (2013-2018)
Table United States Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Players (2013-2018)
Table United States Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Players (2013-2018)
Figure United States Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Players in 2017
Table United States Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Type (2013-2018)
Table United States Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Type (2013-2018)
Figure United States Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Type in 2017
Table United States Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Application (2013-2018)
Table United States Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Application (2013-2018)
Figure United States Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Application in 2017
Figure Europe Checkpoint Inhibitors for Treating Cancer Sales (g) and Growth Rate (2013-2018)
Figure Europe Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Checkpoint Inhibitors for Treating Cancer Sales Price (USD/mg) Trend (2013-2018)
Table Europe Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Players (2013-2018)
Table Europe Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Players (2013-2018)
Figure Europe Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Players in 2017
Table Europe Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Type (2013-2018)
Table Europe Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Type (2013-2018)
Figure Europe Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Type in 2017
Table Europe Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Application (2013-2018)
Table Europe Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Application (2013-2018)
Figure Europe Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Application in 2017
Figure China Checkpoint Inhibitors for Treating Cancer Sales (g) and Growth Rate (2013-2018)
Figure China Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Checkpoint Inhibitors for Treating Cancer Sales Price (USD/mg) Trend (2013-2018)
Table China Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Players (2013-2018)
Table China Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Players (2013-2018)
Figure China Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Players in 2017
Table China Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Type (2013-2018)
Table China Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Type (2013-2018)
Figure China Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Type in 2017
Table China Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Application (2013-2018)
Table China Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Application (2013-2018)
Figure China Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Application in 2017
Figure Japan Checkpoint Inhibitors for Treating Cancer Sales (g) and Growth Rate (2013-2018)
Figure Japan Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Checkpoint Inhibitors for Treating Cancer Sales Price (USD/mg) Trend (2013-2018)
Table Japan Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Players (2013-2018)
Table Japan Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Players (2013-2018)
Figure Japan Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Players in 2017
Table Japan Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Type (2013-2018)
Table Japan Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Type (2013-2018)
Figure Japan Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Type in 2017
Table Japan Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Application (2013-2018)
Table Japan Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Application (2013-2018)
Figure Japan Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Application in 2017
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales (g) and Growth Rate (2013-2018)
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Price (USD/mg) Trend (2013-2018)
Table Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Players (2013-2018)
Table Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Players in 2017
Table Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Type (2013-2018)
Table Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Type in 2017
Table Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Application (2013-2018)
Table Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Application in 2017
Figure India Checkpoint Inhibitors for Treating Cancer Sales (g) and Growth Rate (2013-2018)
Figure India Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Checkpoint Inhibitors for Treating Cancer Sales Price (USD/mg) Trend (2013-2018)
Table India Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Players (2013-2018)
Table India Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Players (2013-2018)
Figure India Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Players in 2017
Table India Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Type (2013-2018)
Table India Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Type (2013-2018)
Figure India Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Type in 2017
Table India Checkpoint Inhibitors for Treating Cancer Sales Volume (g) by Application (2013-2018)
Table India Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Application (2013-2018)
Figure India Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share by Application in 2017
Table Bristol-Myers Squibb(BMS) Basic Information List
Table Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Sales Global Market Share (2013-2018)
Figure Bristol-Myers Squibb(BMS) Checkpoint Inhibitors for Treating Cancer Revenue Global Market Share (2013-2018)
Table Merck Basic Information List
Table Merck Checkpoint Inhibitors for Treating Cancer Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2013-2018)
Figure Merck Checkpoint Inhibitors for Treating Cancer Sales Growth Rate (2013-2018)
Figure Merck Checkpoint Inhibitors for Treating Cancer Sales Global Market Share (2013-2018)
Figure Merck Checkpoint Inhibitors for Treating Cancer Revenue Global Market Share (2013-2018)
Table Roche Basic Information List
Table Roche Checkpoint Inhibitors for Treating Cancer Sales (g), Revenue (Million USD), Price (USD/mg) and Gross Margin (2013-2018)
Figure Roche Checkpoint Inhibitors for Treating Cancer Sales Growth Rate (2013-2018)
Figure Roche Checkpoint Inhibitors for Treating Cancer Sales Global Market Share (2013-2018
Figure Roche Checkpoint Inhibitors for Treating Cancer Revenue Global Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Checkpoint Inhibitors for Treating Cancer
Figure Manufacturing Process Analysis of Checkpoint Inhibitors for Treating Cancer
Figure Checkpoint Inhibitors for Treating Cancer Industrial Chain Analysis
Table Raw Materials Sources of Checkpoint Inhibitors for Treating Cancer Major Players in 2017
Table Major Buyers of Checkpoint Inhibitors for Treating Cancer
Table Distributors/Traders List
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Volume (g) and Growth Rate Forecast (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Price (USD/mg) and Trend Forecast (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Sales Volume (g) Forecast by Regions (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share Forecast by Regions in 2025
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share Forecast by Regions in 2025
Figure United States Checkpoint Inhibitors for Treating Cancer Sales Volume (g) and Growth Rate Forecast (2018-2025)
Figure United States Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Checkpoint Inhibitors for Treating Cancer Sales Volume (g) and Growth Rate Forecast (2018-2025)
Figure Europe Checkpoint Inhibitors for Treating Cancer Revenue and Growth Rate Forecast (2018-2025)
Figure China Checkpoint Inhibitors for Treating Cancer Sales Volume (g) and Growth Rate Forecast (2018-2025)
Figure China Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Checkpoint Inhibitors for Treating Cancer Sales Volume (g) and Growth Rate Forecast (2018-2025)
Figure Japan Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Sales Volume (g) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Checkpoint Inhibitors for Treating Cancer Sales Volume (g) and Growth Rate Forecast (2018-2025)
Figure India Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Sales (g) Forecast by Type (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Revenue Market Share Forecast by Type (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Price (USD/mg) Forecast by Type (2018-2025)
Table Global Checkpoint Inhibitors for Treating Cancer Sales (g) Forecast by Application (2018-2025)
Figure Global Checkpoint Inhibitors for Treating Cancer Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources